Triple negative breast cancer (TNBC), characterized as being negative for estrogen receptor (ER), progesterone receptor (PR), and human epidermal receptor growth factor 2 (HER2), is the second most common breast cancer subtype and has the worst prognosis. Here, ESR1 is linked to triple-negative breast carcinoma.